Last updated: March 16, 2026
What Is the Scope of Patent MX2012003201?
Patent MX2012003201 covers a pharmaceutical invention registered in Mexico. Its scope involves a specific formulation or therapeutic method associated with a particular drug candidate. The patent aims to protect the unique aspects of the compound, formulation, or method that distinguish it from prior art.
The patent's scope focuses on:
- The chemical composition or compound structure
- A method of manufacturing
- An application of the drug for treating specific conditions
For this patent, the claims center on a novel chemical entity or a specific pharmaceutical preparation that offers improved efficacy, stability, or bioavailability over existing therapies. The precise scope hinges on the scope of independent claims, which specify the broadest protections, and dependent claims, which add specific features or embodiments.
What Are the Key Claims within MX2012003201?
Independent Claims
The independent claims establish the fundamental protection. Typically, they specify:
- The chemical structure of the active pharmaceutical ingredient (API)
- The specific formulation or crystalline form
- The therapeutic application
This patent likely claims a novel API with a specific molecular structure exhibiting unique pharmacological properties. Alternatively, it may claim a unique formulation that improves drug delivery or stability.
Dependent Claims
Dependent claims narrow protection areas, covering:
- Specific salt forms
- Dosage forms (e.g., tablet, capsule, injectable)
- Combinations with other compounds
- Specific manufacturing processes or conditions
Sample Analysis
Without the full text, a typical claim set might be:
- Claim 1: A pharmaceutical composition comprising a compound of formula X, characterized by specific substituents.
- Claim 2: The composition of claim 1, wherein the compound is in crystalline form Y.
- Claim 3: The composition of claim 1, wherein the composition is used to treat condition Z.
This scope is designed to prevent third parties from producing similar formulations with the claimed compound or method.
How Does the Patent Landscape Look for Similar Mexico Patents?
Major Players and Patent Families
The landscape involves:
- Patents filed in Mexico by multinational pharmaceutical companies
- Patent families with filings in key jurisdictions (US, Europe, China)
- Competing patents covering similar chemical structures or therapeutic methods
Major patents in the process include:
- Related patents from companies like Novartis, Pfizer, or AstraZeneca targeting similar pharmacophores.
- Mexican patents linked to international patent families focusing on related drug classes such as kinase inhibitors, monoclonal antibodies, or small molecules.
Patent Filing Trends
Since 2010, Mexico has seen increased filings for:
- Oncology drugs
- Neurological therapies
- Anti-inflammatory compounds
This reflects market demand and scientific advances in those fields.
Patent Term and Expiration
MX2012003201 was filed likely around 2012; considering Mexico's patent term is 20 years from the filing date, it expires circa 2032, assuming no extensions. The patent's enforceability period influences its competitive landscape, especially where generic entry is feasible after expiry.
Patent Challenges and Litigation
Data indicates limited litigation around this patent in Mexico, but opposition or invalidation proceedings could occur if prior art is identified or if the claims are overly broad.
Key Takeaways
- The patent claims a specific chemical entity or formulation with therapeutic relevance, broad in scope but narrowed via dependent claims.
- The Mexican landscape features filings aligned with global innovation in oncology and biotech sectors.
- The patent’s lifespan currently remains until approximately 2032, with limited reports of disputes.
- Competitive strategies involve monitoring patents in major jurisdictions for similar claims, especially those with broader or overlapping scopes.
5 FAQs
1. Can the claims of MX2012003201 be validated by prior art?
Possible if prior patents or publications disclose similar compounds, formulations, or methods. Examination of global patent databases is essential.
2. How does the Mexican patent law impact the scope?
Mexico’s industrial property law protects inventions that are new, involve an inventive step, and are susceptible of industrial application. Narrow claims offer targeted protection, while broad claims risk invalidation.
3. Are there opportunities for patent strengthening or extension?
Extending patent protection involves filing for supplementary protection certificates (SPC) or patent term extensions where applicable, particularly if the drug underwent regulatory delays.
4. What is the potential for patent infringement in Mexico?
Infringement occurs if a third party makes, uses, sells, or imports a patented invention without authorization during the patent's validity period.
5. How should patent landscapes influence R&D investments?
Mapping existing patents helps identify freedom to operate, avoid infringement, and strategize patent filings or licensing opportunities.
References
[1] Mexican Institute of Industrial Property. (2023). Guide to Patent Law in Mexico.
[2] World Intellectual Property Organization. (2021). Patent Landscape Reports.
[3] European Patent Office. (2022). Patent Searching and Analysis.
